EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 39 filers reported holding EVELO BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $310,000 | -54.7% | 96,174 | +1.7% | 0.00% | – |
| Q4 2021 | $685,000 | -19.1% | 94,570 | -6.9% | 0.00% | – |
| Q3 2021 | $847,000 | -43.1% | 101,535 | -6.3% | 0.00% | – |
| Q2 2021 | $1,489,000 | +109.1% | 108,406 | +63.0% | 0.00% | – |
| Q1 2021 | $712,000 | +6.0% | 66,499 | +19.5% | 0.00% | – |
| Q4 2020 | $672,000 | +154.5% | 55,652 | +11.1% | 0.00% | – |
| Q3 2020 | $264,000 | +65.0% | 50,083 | +53.8% | 0.00% | – |
| Q2 2020 | $160,000 | +15.9% | 32,557 | -11.5% | 0.00% | – |
| Q1 2020 | $138,000 | -1.4% | 36,767 | +6.9% | 0.00% | – |
| Q4 2019 | $140,000 | -33.3% | 34,395 | 0.0% | 0.00% | – |
| Q3 2019 | $210,000 | -36.6% | 34,395 | -6.8% | 0.00% | – |
| Q2 2019 | $331,000 | – | 36,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 484,953 | $1,823,000 | 4.61% |
| Flagship Pioneering Inc. | 18,233,403 | $68,558,000 | 3.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $6,622,000 | 3.20% |
| Alphabet Inc. | 1,060,495 | $3,982,000 | 0.26% |
| Larson Financial Group LLC | 20,042 | $75,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,500 | $501,000 | 0.01% |
| CREDIT SUISSE AG/ | 1,500,117 | $5,633,000 | 0.01% |
| FMR LLC | 3,220,853 | $12,094,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 177,856 | $668,000 | 0.00% |
| Legal & General Group Plc | 1,522 | $6,000 | 0.00% |